|
RBM17 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.254400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.879600E-01 |
| Normal-vs-Stage2 |
3.019400E-01 |
| Normal-vs-Stage3 |
2.335000E-01 |
| Normal-vs-Stage4 |
3.925200E-01 |
| Stage1-vs-Stage2 |
2.238200E-01 |
| Stage1-vs-Stage3 |
2.668000E-01 |
| Stage1-vs-Stage4 |
5.204600E-01 |
| Stage2-vs-Stage3 |
8.477600E-01 |
| Stage2-vs-Stage4 |
9.409400E-01 |
| Stage3-vs-Stage4 |
9.341400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.164400E-01 |
| Normal-vs-AfricanAmerican |
5.161800E-01 |
| Normal-vs-Asian |
2.178800E-01 |
| Caucasian-vs-AfricanAmerican |
2.988800E-01 |
| Caucasian-vs-Asian |
2.646200E-01 |
| AfricanAmerican-vs-Asian |
6.379000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.054000E-01 |
| Normal-vs-Female |
4.117600E-01 |
| Male-vs-Female |
1.875200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.440200E-01 |
| Normal-vs-Extreme_Weight |
7.255400E-01 |
| Normal-vs-Obese |
9.725000E-01 |
| Normal-vs-Extreme_Obese |
2.790200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.123800E-01 |
| Normal_Weight-vs-Obese |
4.252400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.973400E-01 |
| Extreme_Weight-vs-Obese |
7.210800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.733000E-01 |
| Obese-vs-Extreme_Obese |
2.876200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.969700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.374600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.403200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.698340E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.728230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.178600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.303330E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.087500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.563600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.931500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.285610E-01 |
| Normal-VS-Type2 PRCC |
2.635400E-04 |
| Normal-VS-KIRP CIMP |
2.432600E-01 |
| Normal-VS-Unclassified PRCC |
3.970600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.66250404740754E-11 |
| Type1 PRCC-VS-KIRP CIMP |
7.796800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.424030E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.771900E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.698800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
9.109500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.108300E-02 |
| Normal-vs-N1 |
4.694600E-01 |
| Normal-vs-N2 |
5.386600E-01 |
| N0-vs-N1 |
1.018410E-01 |
| N0-vs-N2 |
8.046600E-01 |
| N1-vs-N2 |
5.649200E-01 |
|
|
